Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?

Authors: Shinkichi Takamori, PhD, Mitsuhiro Takenoyama, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

Malignant pleural mesothelioma (MPM) is traditionally considered resistant to chemotherapy or multidisciplinary therapy, and identification of prognostic factors is important. According to previous reports, the prognostic significance of clinical stage has been controversial in MPM patients, which is likely attributable to the reportedly poor diagnostic accuracy of computed tomography images for lymph node metastasis and T factor. Therefore, a prognostic factor with high objectivity and reproducibility would be important. Our previous study has suggested that the serum nutritional status of a patient would be a significant prognostic indicator in MPM patients1; however, on the other hand, inflammation-based indices are also widely believed to be significant prognostic factors.2 We thus investigated the clinical utility of a novel index, C-reactive protein (CRP)/albumin ratio (CAR), which reflects both nutritional and inflammatory statuses. The CAR has already been used to predict treatment outcome in patients with gastric, esophageal, and ovarian cancer. The present study aimed to clarify the prognostic significance of CAR in MPM patients. …
Literature
1.
go back to reference Takamori S, Toyokawa G, Taguchi K, et al. The controlling nutritional status score is a significant independent predictor of poor prognosis in patients with malignant pleural mesothelioma. Clin Lung Cancer. 2017;18(4):e303–e13.CrossRefPubMed Takamori S, Toyokawa G, Taguchi K, et al. The controlling nutritional status score is a significant independent predictor of poor prognosis in patients with malignant pleural mesothelioma. Clin Lung Cancer. 2017;18(4):e303–e13.CrossRefPubMed
2.
go back to reference Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol. 2012;7(3):587–94.CrossRefPubMed Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol. 2012;7(3):587–94.CrossRefPubMed
3.
go back to reference Takamori S, Toyokawa G, Shimokawa M, et al. The C-reactive protein/albumin ratio is a novel significant prognostic factor in patients with malignant pleural mesothelioma: a retrospective multi-institutional study. Ann Surgl Oncol. 2018;25(6):1555–63.CrossRef Takamori S, Toyokawa G, Shimokawa M, et al. The C-reactive protein/albumin ratio is a novel significant prognostic factor in patients with malignant pleural mesothelioma: a retrospective multi-institutional study. Ann Surgl Oncol. 2018;25(6):1555–63.CrossRef
4.
go back to reference China L, Maini A, Skene SS, et al. Albumin counteracts immune-suppressive effects of lipid mediators in patients with advanced liver disease. Clin Gastroenterol Hepatol. 2018;16(5):738–47.CrossRefPubMedCentralPubMed China L, Maini A, Skene SS, et al. Albumin counteracts immune-suppressive effects of lipid mediators in patients with advanced liver disease. Clin Gastroenterol Hepatol. 2018;16(5):738–47.CrossRefPubMedCentralPubMed
5.
go back to reference Shigematsu Y, Hanagiri T, Kuroda K, et al. Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers. Cancer Sci. 2009;100(7):1326–34.CrossRefPubMed Shigematsu Y, Hanagiri T, Kuroda K, et al. Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers. Cancer Sci. 2009;100(7):1326–34.CrossRefPubMed
Metadata
Title
ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?
Authors
Shinkichi Takamori, PhD
Mitsuhiro Takenoyama, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6920-9

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue